These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3154640)

  • 1. OPC-8212 in the treatment of congestive heart failure: results of a pilot study.
    Kubo SH; Rector TS; Strobeck JE; Cohn JN
    Cardiovasc Drugs Ther; 1988 Dec; 2(5):653-60. PubMed ID: 3154640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral OPC-8212 for the treatment of congestive heart failure: hemodynamic improvement and increased exercise capacity.
    Inoue M; Kim BH; Hori M; Tsuneoka Y; Matsubara N; Kamada T; Kodama K; Naka M; Nanto S; Higashino Y
    Heart Vessels; 1986; 2(3):166-71. PubMed ID: 3793669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
    Feldman AM; Baughman KL; Lee WK; Gottlieb SH; Weiss JL; Becker LC; Strobeck JE
    Am J Cardiol; 1991 Nov; 68(11):1203-10. PubMed ID: 1951080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.
    Sasayama S; Inoue M; Asanoi H; Kodama K; Hori M; Sakurai T; Kawai C
    Heart Vessels; 1986; 2(1):23-8. PubMed ID: 3722083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure.
    Feldman AM; Becker LC; Llewellyn MP; Baughman KL
    Am Heart J; 1988 Sep; 116(3):771-7. PubMed ID: 3046278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure. OPC-8212 Multicenter Research Group.
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):419-25. PubMed ID: 2285626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel inotropic agent (OPC-18790) on systolic and diastolic function in patients with severe heart failure.
    Hoit BD; Burwig S; Eppert D; Bhat G; Walsh RA
    Am Heart J; 1994 Dec; 128(6 Pt 1):1156-63. PubMed ID: 7985596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.
    Abraham WT; Lowes BD; White M; Ferguson DA; Scheffel CA; Wolfel EE; Lindenfeld J; Bristow MR
    J Card Fail; 1994 Oct; 1(1):57-62. PubMed ID: 9420633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic effects of a new inotropic agent (OPC-8212) in patients with congestive heart failure.
    Asanoi H; Sasayama S; Iuchi K; Kameyama T
    J Am Coll Cardiol; 1987 Apr; 9(4):865-71. PubMed ID: 3558984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter study of a new inotropic agent, piperanometozine (OPC-8212) in congestive heart failure: clinical improvement during short-term treatment.
    Inoue M; Hori M; Yasuda H; Takishima T; Sugimoto T; Sasayama S; Sakurai T; Nonogi H; Kodama K; Kusukawa R
    Cardiovasc Drugs Ther; 1987 Aug; 1(2):169-75. PubMed ID: 3154320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure.
    Anand I; Chandrashekhan Y; De Giuli F; Pasini E; Mazzoletti A; Confortini R; Ferrari R
    Cardiovasc Drugs Ther; 1998 Jul; 12(3):291-9. PubMed ID: 9784909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
    Kanda H; Yokota M; Ishihara H; Nagata K; Kato R; Sobue T
    Am Heart J; 1996 Aug; 132(2 Pt 1):361-8. PubMed ID: 8701899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained inotropic effects of a new cardiotonic agent. OPC-8212 in patients with chronic heart failure.
    Asanoi H; Sasayama S; Kameyama T; Ishizaka S; Iuchi K
    Clin Cardiol; 1989 Mar; 12(3):133-8. PubMed ID: 2647327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.
    Klauss V; Zwehl W; Mudra H; Huber R; Schmidt R; Scheininger M; Vogler A; Tschaidse O; Dieterich HA; Theisen K
    Klin Wochenschr; 1991 Jul; 69(10):430-5. PubMed ID: 1719270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.
    Katz SD; Kubo SH; Jessup M; Brozena S; Troha JM; Wahl J; Cohn JN; Sonnenblick EH; LeJemtel TH
    Am Heart J; 1992 Jan; 123(1):95-103. PubMed ID: 1729854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
    Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct myocardial effects of OPC-18790 in human heart failure: beneficial effects on contractile and diastolic function demonstrated by intracoronary infusion with pressure-volume analysis.
    MacGowan GA; Haber HL; Cowart TD; Tedesco C; Wu C; Feldman MD
    J Am Coll Cardiol; 1998 May; 31(6):1344-51. PubMed ID: 9581731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the effectiveness of toborinone (OPC-18790) in the treatment of heart failure in patients following cardiac surgery.
    Hirata T; Akamatsu T; Horinokuchi N; Uchida O; Kuro M
    Arzneimittelforschung; 1999 Jun; 49(6):499-503. PubMed ID: 10417865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
    Uretsky BF; Seecof RM; Reddy PS
    Can J Cardiol; 1986; 2(2):80-5. PubMed ID: 3085906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-invasive evaluation of flosequinan on haemodynamics and exercise capacity in chronic congestive heart failure.
    Motro M; Freimark D; Feinberg MS; Wynne RD; King C; Schneeweiss A
    Int J Clin Pharmacol Res; 1993; 13(3):143-9. PubMed ID: 8225697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.